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 Drug named entity recognition (DNER) becomes the prerequisite of other 
medical relation extraction systems. Existing approaches to automatically 
recognize drug names includes rule-based, machine learning (ML) and deep 
learning (DL) techniques. DL techniques have been verified to be the state-
of-the-art as it is independent of handcrafted features. The previous DL 
methods based on word embedding input representation uses the same vector 
representation for an entity irrespective of its context in different sentences 
and hence could not capture the context properly. Also, identification of the 
n-gram entity is a challenge. In this paper, a novel architecture is proposed 
that includes a sentence embedding layer that works on the entire sentence to 
efficiently capture the context of an entity. A hybrid model that comprises a 
stacked bidirectional long short-term memory (Bi-LSTM) with residual 
LSTM has been designed to overcome the limitations and to upgrade the 
performance of the model. We have contrasted the achievement of our 
proposed approach with other DNER models and the percentage of 
improvements of the proposed model over LSTM-conditional random field 
(CRF), LIU and WBI with respect to micro-average F1-score are 11.17, 8.8 
and 17.64 respectively. The proposed model has also shown promising result 
in recognizing 2- and 3-gram entities. 
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Named entity recognition (NER) is an essential task of information extraction (IE), and is often 
utilized in natural language processing (NLP). The NER that defines and classifies the labels of drugs into 
predefined classes from unstructured medical texts is referred to as drug named entity recognition  
(DNER) [1]. The research on the DNER becomes prominent ever since the identification of drug-drug 
interactions (DDI) and adverse drug reaction (ADR) have become important in the branch of 
pharmacodynamics and pharmacokinetics. However, many studies [2]-[5] have shown that there is not much 
specific work for DNER in recent years. Techniques like rule-based framework, machine learning (ML) 
methods and deep learning (DL) techniques were employed for the DNER. The rule-based and ML 
techniques heavily depend on the field/subject knowledge of the human professionals to devise the features 
for designing the recognition model. DL uses more than one layer of artificial neural networks that 
recognizes the named entities [2], [6]–[8]. When compared to traditional approaches, DL is more 
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advantageous in automatically recognizing hidden features. The latest DL techniques do not require the 
intervention of the human experts in constructing the features from unstructured text. The most common DL 
model used is long short-term memory (LSTM) which helps to preserve the long-range dependency 
especially while dealing with sequential text. Bidirectional LSTM model (Bi-LSTM) which reads the text 
both in forward and reverse directions is used to capture the context of the word for better prediction. Word 
embedding models like Word2Vec, GloVe and FastText are usually used for word embedding in DL 
algorithms. We have observed that the major limitation of word embedding models is that they work with the 
same vector for all the mentions of an entity in the article and hence could not capture the context properly.  
The previous research works for DNER models based on DL have used word2vec [9] and  
Glove [10] word embedding and character embedding models to represent the input. It was found that the 
word embedding model could not capture the semantic feature of the words in the sentence completely. 
Because in word2vec, every unique word throughout the corpus will have the same vector in the vector 
space. Consider the following sentences:  
 Sentence 1: MAO inhibitors prolong and intensify the anticholinergic (drying) effects of antihistamines. 
(MAO – B-group, inhibitors – I-group).  
 Sentence 2:  In the absence of formal clinical drug interaction studies, caution should be exercised when 
administering TAXOL concomitantly with known substrates or inhibitors of the cytochrome P450 
isoenzymes CYP2C8 and CYP3A4.  
In sentence 1, the word “MAO inhibitors” is annotated as a class of drug ‘group’ and hence 
“inhibitors” is annotated with “I-group”. But in sentence 2, the word “inhibitors” does not refer to any class 
of drug and hence should be identified as “O”. If word embedding models like Word2Vec or Glove are used, 
the same word vector is used for both the mentions and hence would not be recognized correctly based on the 
context. Though recurrent neural networks (RNN) have been used for various NER models, the full potential 
is not realized when an LSTM or Bi-LSTM model alone is used. Also, in DNER, several drug names are  
n-gram entities. For instance, “albendazole sulfoxide” (2-gram entity), “central nervous system depressants” 
(4-gram entity). 
In this paper, to overcome the challenges mentioned above, a novel architecture has been proposed 
by incorporating a sentence embedding model, stacked Bi-LSTM and residual LSTM. A sentence embedding 
model called ELMo [11], is used to deal with entire sentence to capture the context properly. Since the model 
is extremely contextualized, both syntax and semantic characteristics of the word are modelled. The main 
advantage is that it would be able to generate vectors for words that are not seen during training. Also, to 
enhance the DNER model, the designed architecture utilizes the power of the RNN in drug prediction. The 
architecture consists of stacked Bi-LSTM layers [12] and a residual LSTM layer [13]. 
 Initially, the sentence embedding model ELMo used in this architecture creates word vectors by 
functioning on an entire sentence to efficiently capture the context of the word. The specific context and the 
variations in the content is identified and helps the machine to understand better, unlike having the same 
word vector for every mention of the word in other word embedding models. Though a single Bi-LSTM layer 
itself could possibly recognize the entities, the power of the RNN shall be enhanced by arranging multiple 
Bi-LSTM layers on top of each other. We have experimented with layers of Bi-LSTM in this model. To 
avoid stacked Bi-LSTM suffering from the vanishing gradient problem, the residual LSTM is used. The 
residual connection is used between the two Bi-LSTM layers. It allows the gradients to pass through the 
network directly and also helps to preserve the long range dependencies [14], [15]. We have tested our 
proposed approach with a test data set and the performance is compared with other DNER models and found 
to improve the recognition rate over the preceding state-of-the-art models. We have also evaluated the 
performance in identifying the 2-, 3-, and 4- gram entities which is a major challenge in DNER. The content 
of this paper is categorized as follows: section 2 extends the research method. Results are discussed in section 3 
and conclusion is given in section 4. 
 
 
2. RESEARCH METHOD 
In our model, we have used Bi-LSTM network where the sentence is read in both forward and 
reverse direction. The works represented in the following papers [16]-[19] have shown that the classification 
performance could be enhanced further by stacking many Bi-LSTM layers. Hence, in our model, we have 
used two Bi-LSTM layers stacked above each other as shown in Figure 1. When the sentences are long as 
given in the example in section 1, it is necessary to remember the long range dependency of the entity from 
the first instance and the next instance. When the depth of the neural network increases, accuracy of 
prediction also increases. Residual LSTM is used to avoid stacked Bi-LSTM suffering from the vanishing 
gradient problem and also it is suitable for handling such long range dependencies.  
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2.1.  Data source and preprocessing 
In this paper, we have adopted the tagged corpus namely, the DDI2013 drugbank dataset [20], the 
benchmark dataset to train the deep learning model. The data is categorized with the following labels: drug, 
brand, group and drug_n [20]. We have preprocessed the DDI2013 training dataset in such a way that the 
sentence is split into tokens and every token is labeled with the corresponding class labels. Since there are 
several n-gram words available as drug names in the biomedical articles, it is necessary to capture the 
beginning and end of the entity. The most common tagging scheme known as BIO tagging is useful to 
capture these details. Table 1 gives the count of the various BIO tags available in the training dataset. In BIO 
tagging, B, I and O correspond to the beginning, inside and outside or non-entity token respectively. For 
example, the label B-group, I-group represent the beginning and inside of the group respectively and O 
represents non-entity tokens.  
 
 
Table 1. Tags and its counts 
Tag B-brand I-brand B-drug I-drug B-group I-group B-drug_n I-drug_n 
Count 1425 48 8333 549 3027 1937 96 29 
 
 
2.2.    Components of the model 
2.2.1. Sentence embedding layer 
 Sentence embedding techniques addresses whole sentences and their semantic data as vectors. This 
aids the machine in understanding the specific context and different subtleties in the whole content. ELMo 
(embedding from language models) is an embedding model [11] which functions for an entire sentence. The 
word representation used in this model is deeply contextualized that can model characteristics such as syntax 
and semantics of the word and also finds how these characteristics can be used for different linguistic 
contexts [21]. Since this is also a character based representation, instead of simply looking into words and 
their vectors, it generates vectors that form representations of tokens that are not seen during training. 
 
2.2.2.  Stacked Bi-LSTM layers 
Bi-LSTM, which took its idea from bidirectional RNN that proceeds in both directions – forward 
and reverse – having independent hidden layers for each direction. These hidden layers are linked to a 
common output layer. Bi-LSTM networks are found to be better in many research areas such as traffic 
prediction [12], speech recognition [22] and phoneme classification [23].  
The previous studies [22], [23] have proved that deep LSTM models ie. stacked LSTM models with 
many hidden layers can develop a successively more significant level of description for the sequential data 
and hence could perform more effectively as illustrated in [12] using a two-layer Bi-LSTM model for traffic 
prediction. The effectiveness of stacked Bi-LSTM networks for better classification and regression tasks was 
also demonstrated in [17], [18], and [24]. 
In our work, based on the previous research works, we have also adopted the two layers of stacked 
Bi-LSTM. The lower layer of Bi-LSTM is more appropriate for extracting useful information from the input 
vectors. The unique vectors obtained for each word in the sentence using the sentence embedding model is 
given as input to the Bi-LSTM layer 1 which helps in capturing the features for predicting the drug 
categories. As we have used two stacked layers, the second layer or the top layer of the stack utilizes the 
features learned from the output of the lower layer. It also learns many complex features to enhance the 
achievement of the model. 
 
2.2.3.  Residual LSTM connection 
To overcome the issue of vanishing gradients, a residual LSTM connection is used which provides a 
bypass link between the layers [13]. The shortcut path could be from any lower layers. In this paper, we have 
used residual LSTM as a shortcut between the stacked Bi-LSTM layers. Since we have used only two stacked 
Bi-LSTM layers, the shortcut is taken from the output of layer 1 and added with the output of layer 2 as 
shown in Figure 1. 
 
2.3.  Architecture of the proposed system 
The system architecture of the proposed model for DNER system is shown in Figure 2. The main 
novelty of this architecture is the inclusion of sentence embedding layer which enables the system to capture 
the semantic information better than word or character embedding models. In addition, the architecture 
comprises of stacked Bi-LSTM (with two layers) and residual LSTM to capture the complex features of the 
sentences and to overcome the problem of vanishing gradients respectively.  
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Consider an input sequence w=(w1, w2,…wn) where w1,..wn represents the words in the sequence 
padded with a fixed length for each sentence and series of output tags e=(e1, e2…en) where e1, e2,..en refers to 
entities. The sentence embedding layer ELMo creates the vector to every word for sentence w. The input for 
Bi-LSTM layer 1 is the sequence of word vectors found from the sentence embedding layer. The sequence of 
hidden states forms the output of the layer 1 and that in turn becomes the input to the Bi-LSTM layer 2. The 











Figure 2. System architecture of the proposed model 
 
 
In the forward layer, the input sequence 𝑤𝑡  is fed from time t=1 to Tn and from t=Tn to 1 in the 
reverse layer. The hidden vector sequence and the output sequence are computed from the Bi-LSTM layer. 
The hidden vector sequence can be forward sequence and reverse sequence represented by 𝑠𝑡  𝑎𝑛𝑑 ?⃖?𝑡 
respectively. The forward layer is iterated from t=1 to Tn and the reverse layer is iterated from t=Tn to 1. The 
calculation of forward hidden vector, reverse hidden vector and output sequence respectively are shown as in 
(1), (2) and (3). 
 
𝑠𝑡  = 𝐻(𝑊𝑤𝑠𝑤𝑡 + 𝑊𝑠𝑠𝑠𝑡−1 + 𝑏𝑠)        (1) 
 
?⃖?𝑡 = 𝐻(𝑊𝑤?⃖?𝑤𝑡 + 𝑊?⃖??⃖??⃖?𝑡+1 + 𝑏?⃖?)         (2) 
 
𝑦𝑡 = 𝑊𝑠𝑦𝑠𝑡 + 𝑊?⃖?𝑦?⃖?𝑡 + 𝑏𝑦       (3) 
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Where 𝐻 symbolizes the hidden layer function, 𝑊 symbolizes the various weight matrices, 𝑏 symbolizes the 
bias vectors and 𝑦𝑡  denotes the output layer variable. The weights 𝑊𝑤𝑠 , 𝑊𝑠𝑠 , 𝑊𝑤?⃖?, 𝑊?⃖??⃖?  and the biases 𝑏𝑠 , 
𝑏?⃖? represents the model parameters in (1) and (2). Then the bias parameter 𝑏𝑦 is concatenated with forward 
hidden layer 𝑠𝑡  and reverse hidden layer ?⃖?𝑡 to get the output layer 𝑦𝑡  as in (3). In general, when more than 
one Bi-LSTM layer is used, the forward and reverse hidden sequence can be computed for n=1 to N and t=1 






𝑛)       (4) 
 
?⃖?𝑡
𝑛 = 𝐻(𝑊?⃖?𝑛−1 ?⃖?  𝑛𝑠𝑡
𝑛−1 + 𝑊?⃖?𝑛?⃖?𝑛𝑠𝑡
𝑛 + 𝑏𝑠
𝑛)      (5) 
 
The output sequence is calculated as given in (6). 
 
𝑦𝑡 = 𝑊𝑠𝑁𝑠𝑡
𝑁 + 𝑏𝑦              (6) 
 
Now, the residual LSTM connection is applied by adding the output sequences of Bi-LSTM layer 2 with w. It 
is referred by H(w) and is shown in (7). 
 
𝐻(𝑤) =  𝑦𝑡 + 𝑤                 (7) 
 
The vanishing gradient problem could be resolved by the application of residual LSTM since the gradients 
could pass through the layers directly by using the addition operator. The residual LSTM [13] permits 
different layers of LSTM to adequately train complex networks with an optional temporal shortcut path from 
deeper levels. Finally, the scores given for each label by the Bi-LSTM layers are provided as an input into the 
softmax classifier output layer 𝑂𝑤, as given in (8). 
 
𝑂𝑤 = 𝑠𝑜𝑓𝑡𝑚𝑎𝑥(𝐻(𝑤))         (8) 
 
This layer produces the predicted probabilities for all the labels to each word used for classification which 
includes B-drug, I-drug, B-brand, I-brand, B-group, I-group and O. The label which has got the highest 
prediction in the sequence would be considered as the label for the word. 
 
2.4.  Pseudocode of the proposed DNER Model 
The general steps of the proposed DNER system based on stacked Bi-LSTM and residual LSTM is 
shown in Algorithm 1. 
 
Algorithm 1:   
1 Input Sentences of various lengths from DDI2013 Drugbank training 
dataset. 
2 Preprocessing Tokenize the sentences from the input dataset. 
3 For each token, include Part-of-Speech (POS) tags and BIO drug 
labels. 
4 Each tokenized sentence is padded with _PAD_ tokens to bring it to 
a fixed length. 
5 Model 
Construction  
Construct Sentence embedding using ELMo for the pre-processed input 
dataset. 
6 Implement Stacked Bi-LSTM layers (two layers) to obtain the 
previous and future contextual information for more accurate 
prediction ie. the sequence of hidden vectors obtained from Bi-LSTM 
layer 1 is given to Bi-LSTM layer 2 using (2),(3),(4),(5,(6), and 
(7). 
7 Establish a Residual connection using a vector addition between the 
Bi-LSTM layer 1 output and Bi-LSTM layer 2 output to prevent Bi-
LSTM suffering from the vanishing gradient problem as in (8) 
8 Finally, apply softmax function in the output layer to classify 
drug names into multiple categories of drugs as in (9) 
 
 
3. RESULTS AND DISCUSSION 
3.1.   Performance metrics 
The DNER model needs to be evaluated by appropriate and unambiguous metrics to rightly judge 
the performance of the model. Precision, recall and F1-score are used as measurements to assess the model. 
As four different entities are available in DDI2013 corpus, it is necessary to compute the overall performance 
of all the entity classes. In this regard, we take the micro-average F1-score [25] metric for the comparison 
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with other systems. Micro-average F1-score, as in (9) is defined as the harmonic mean of micro-average 
precision (mP) and micro-average recall (mR) and it is given in (10) and (11) respectively. 
 
Micro-average F1-score = 2 * (mP x mR)/(mP + mR), where     (9) 
 
mP=tp1 + tp2 +…+tpn/(tp1 + tp2 +…+tpn + fp1+ fp2 +…+fpn)     (10) 
 
mR=tp1 + tp2 +…+tpn/(tp1 + tp2 +…+tpn + fn1+ fn2 +…+fnn)    (11) 
 
tp, fp and fn represents the true positive, false positive and false negative respectively. 
 
3.2.  Experimental setup 
The datasource used is described in section 2.2. The training data given in DDI2013 drugbank 
corpus is preprocessed and we have used 4990 sentences with 8006 unique words and 30% of the dataset is 
considered as test dataset. We used ‘adam’ optimizer with loss as ‘sparse_categorical_crossentropy’ for 
compiling the model. The batch size is 32 and the number of epochs is made as 8. The recurrent dropout is 
taken as 0.2. The softmax function is fully used in the classifier's output layer as the activation layer where 
the probabilities of identifying the input class are effectively achieved. 
 
3.3.  Result analysis 
Figure 3 shows the detailed results obtained in the form of precision, recall and f1-score for every 
class label of drug entity using the proposed model. The model has performed well with F1-score value of 
more than 85% in categorizing the drug entities except the drug_n class label. This may be due to the fact 
that less number of data is available in the training dataset to learn drug_n class label. However, this could be 
ignored as larger part of the corpus consisting of drug, group and brand labels have been classified 
efficiently.  
Since it is necessary to compute the overall performance of all the entity classes, analysis has been 
carried out  based on the performance metrics shown in (9)-(11) to contrast the proposed model with the 
existing DL based DNER model (LSTM-conditional random field (CRF)) [9] as well as other models from 





Figure 3. Performance of the proposed 
model 
 
Figure 4. Micro-average performance of proposed model vs 
Other DNER models 
 
 
Table 2 shows the results of the performance metrics obtained for each class label for the proposed 
model as well as other DNER systems. In LSTM-CRF, the features are based on both word and character 
level embedding. The percentage of improvement of the proposed model over LSTM-CRF with respect to 
micro-average precision, recall and F1-score are 9.22, 11.19, and 11.17 respectively. 
Liu et al. [26], have experimented a CRF based model (LIU) with semantic features based on word 
embedding. On comparison with this system, our proposed model that uses sentence embedding in stacked 
Bi-LSTM and residual LSTM has improved the micro-average precision, recall and f1-score by 4.18%, 
14.63%, and 8.80% respectively. Rocktäschel et al. [27], studied a model that ranked first in the DDI2013 
challenge studies the impact of domain specific features using linear chain CRF (WBI) for identifying drug 
names. While comparing with this model, a significant improvement of 18.8%, 18.12%, and 17.64% 
respectively for micro-average precision, recall and F1-score is shown by the proposed model. 
Based on the above results, it has been observed that the proposed model performs better as the 
sentence embedding included in the architecture considers the complete sentence for syntax and semantic 
features unlike word embedding which may ignore some of the character features. Even when character level 
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embedding is combined with word embedding as in [9], the sentence level embedding performs better in the 
proposed model in terms of all the micro-averaged performance metrics. In addition, the proposed model 
shows the power of using Bi-LSTM layers that reads the context back and forth in the sentence and captures 
the context well rather than using a single LSTM layer. Also, the automatic extraction of features using 
stacked Bi-LSTM layers in the proposed model is used to recognize entities better than using ML algorithms 
like CRF as in [26], [27]. 
In addition to the above results, the performance of the proposed approach is evaluated to address 
the major concern in the DNER field in identifying the n-gram drug entities where n>1 and the results are 
shown in Table 3. The results are promising in identifying the 2-gram and 3-gram drug entities. However, the 
results can be further improved.  
 
 
Table 2. Comparison of performance metrics-proposed model vs other DNER systems 
Class Label Proposed Model  LSTM-CRF  LIU  WBI 
 Pr Re Fs  Pr Re Fs  Pr Re Fs  Pr Re Fs 
Drug 91.23 88.42 90.37  85.78 80.86 82.59  92.34 85.67 89.54  74.3 85.59 79.32 
Brand 89.32 90.10 89.34  88.22 77.83 82.14  100 95.32 97.21  81.27 86.71 84.77 
Group 89.34 79.31 84.56  86.43 89.29 87.9  89.42 82.49 86.1  79.4 76.22 78.67 
Drug_n 100 40.45 57.67  78.21 57.64 63.48  89.39 14.56 24.75  31.02 90.41 14.2 
Micro-Average 91.12 86.00 88.00  83.62 78.00 79.26  87.46 75.22 80.88  76.7 73.00 74.8 
 
 
Table 3. Percentage of n-gram entities recognized using the proposed model 







In this paper, we have proposed a novel DNER architecture using the latest and advanced DL 
models. It includes stacked Bi-LSTM and a residual LSTM layers. The architecture takes the input in the 
form of vector from sentence level embedding model and outputs the desired drug label sequence with BIO 
tagging scheme. We conducted experiments using DDI2013 drugbank dataset. Our proposed model has 
achieved higher performance than the results obtained using the same dataset with previous state-of-the-art 
models. Besides, the proposed model has shown good results in recognizing 2- and 3- gram entities. The 
future research may be oriented towards further improving the performance using other latest embedding 
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